Search Results 291-300 of 18508 for total bilirubin

1. S1211, Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma - Mayo Clinic

   Total bilirubin ≤ 1.5 times institutional upper limit of normal (IULN); Serum glutamic oxalo-acetic transaminase (SGOT)/aspartate aminotransferase (AST) and ...

2. MAGIC Ruxolitinib For AGVHD - Mayo Clinic

   ... total bilirubin ≥ 3x upper limit of normal not due to GVHD. * A clinical presentation resembling de novo chronic GVHD or overlap syndrome developing before ...

3. A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) - Mayo Clinic

   Aspartate aminotransferase (AST) or Alanine Aminotransferase (ALT) >2.5 x Upper limit of normal (ULN) or total Bilirubin >1.5 x ULN at Visit 1. Note: Other ...

4. ​ Vitamins and supplements for fatty liver disease (MASLD) - Mayo Clinic

   Research suggests that in people who have MASLD, vitamin E may boost the liver's natural antioxidants, help reduce liver inflammation and scarring, and help ...

5. A Study of INCMGA00012 in Squamous Carcinoma of the Anal Canal Following Platinum-Based Chemotherapy - Mayo Clinic

   ... bilirubin only needs to be tested if total bilirubin exceeds ULN). If there is no institutional ULN, then direct bilirubin must be < 40% of total bilirubin.

6. SX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab - Mayo Clinic

   Bilirubin ≤ 1.5 mg/dL (unless diagnosed with Gilbert's syndrome who can have total bilirubin < 3.0 mg/dL);; INR or PT ≤ 1.5 X ULN unless the subject is ...

7. Obinutuzumab With or Without PI3K-delta Inhibitor TGR-1202, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma - Mayo Clinic

   Total bilirubin =< 1.5 x institutional upper limit of normal (IULN) (=< 5 x IULN if secondary to lymphoma, Gilbert's syndrome, or medication related [e.g. ...

8. A Study to Evaluate the Long-Term Effectiveness, Safety, and Tolerability of Repeated Administration of ABT-494 in Patients with Crohn's Disease - Mayo Clinic

   Participation eligibility · Serum AST or ALT > 3.0 × upper limit of normal (ULN) with a total bilirubin > 2 × ULN or international normalized ratio (INR) > 1.5 ...

9. Phase 2 Study to Evaluate the Oral Combination of Ixazomib (MLN9708) With Cyclophosphamide and Dexamethasone in Patients With Newly Diagnosed or Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

   Total bilirubin ≤ 1.5 x the upper limit of the normal range (ULN). Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ≤ 3 x ULN ...

10. Lenalidomide for Myelodysplastic Syndrome Refractory to Hypomethylating Agents - Mayo Clinic

    total bilirubin ≤ 1.5 x ULN; AST (SGOT) and ALT (SGPT) ≤ 3 x ULN. Patient must be disease free of prior malignancies for at least 5 years with exception of ...